Form 4: Herbalife CEO Michael Johnson Acquires Stock Appreciation Rights
SEC Form 4 Filing
Herbalife CEO Michael Johnson was granted stock appreciation rights (SARs) under the company's 2023 Stock Incentive Plan.
Summary
- Michael Johnson, CEO and Chairman of Herbalife Ltd., filed a Form 4 on February 25, 2025, reporting a transaction involving derivative securities.
- The transaction involved the acquisition of 442,477 Stock Appreciation Rights (SARs) at a price of $8.31 each.
- These SARs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
- The SARs will vest in two installments: 50% on February 21, 2026, and 50% on the date of the Company's Annual General Meeting of Shareholders in 2026, contingent upon Johnson's continued service as CEO and/or a member of the Board of Directors.
- Following the reported transaction, Johnson beneficially owns 442,477 derivative securities.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, suggesting a positive alignment of management and shareholder interests. The sentiment is moderately positive as it indicates confidence in the CEO's continued leadership and the company's future performance.
Positives
- The granting of SARs to the CEO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the SARs.
Industry Context
Granting stock appreciation rights is a common practice in corporate governance to align executive compensation with company performance and shareholder value. This is a standard incentive mechanism used across various industries.
Comparison to Industry Standards
- Stock appreciation rights are a common form of executive compensation, similar to stock options, and are used by many companies including Coca-Cola, Pepsico, and Nestle.
- The vesting schedule of the SARs is fairly standard, with vesting occurring over a period of one to two years, which is typical for executive compensation packages.
Stakeholder Impact
- Shareholders may view the granting of SARs positively as it aligns the CEO's interests with the company's performance.
- Employees may see this as a sign of stability and confidence in the company's leadership.
Key Dates
| Date | Description |
|---|---|
| 02/21/2025 | Date of earliest transaction (grant date of SARs) |
| 02/21/2026 | 50% of SARs vest |
| 2026 | Remaining 50% of SARs vest on the date of the Company's Annual General Meeting of Shareholders |
| 02/21/2035 | Expiration date of SARs |
| 02/25/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.